GlassScriptPhysician profile
Patrick G Wetovick
NPI 1588680953
$547.28
in general payments reported to CMS, 2019-2025
16 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.31 · 2020: $42.80 · 2021: $16.20 · 2022: $62.47 · 2023: $145 · 2024: $64.82 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $96.83 | 2019-2024 | Mounjaro |
| Abbvie INC. | $70.30 | 2023-2024 | Dalvance |
| Novo Nordisk INC | $67.58 | 2022-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $50.08 | 2023-2025 | Proclaim, Freestyle Libre 3 |
| Integra Lifesciences Corporation | $48.96 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novartis Pharmaceuticals Corporation | $46.82 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $25.28 | 2019-2020 | |
| Exact Sciences Corporation | $18.42 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $18.21 | 2020 | |
| Boston Scientific Corporation | $17.23 | 2025 | Intracept |
| Amgen INC. | $16.73 | 2019 | |
| Glaxosmithkline, LLC. | $16.20 | 2021 | |
| Organogenesis INC. | $14.97 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.77 | 2025 | Breztri |
| Ultragenyx Pharmaceutical INC. | $12.57 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wetovick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.